|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2007-10-10
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Influenza virosomes represent an innovative human-compatible antigen delivery system that has already proven its suitability for subunit vaccine design. The aim of the study was to proof the concept that virosomes can also be used to elicit high titers of antibodies against synthetic peptides. The specific objective was to demonstrate the safety and immunogenicity of two virosome-formulated P. falciparum protein derived synthetic peptide antigens given in two different doses alone or in combination.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-10392611,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-10469053,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-11920300,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-11948870,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-12009282,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-12547603,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-12783498,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-12874357,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-12934183,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-14506215,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-15212010,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-15488216,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-15639738,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-15752828,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-15805191,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-16372096,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17925866-17098626
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1932-6203
|
|
pubmed:author |
pubmed-author:DegenLukasL,
pubmed-author:GentonBlaiseB,
pubmed-author:KammerAndreas RAR,
pubmed-author:MuellerMarkus MMM,
pubmed-author:OkitsuShinji LSL,
pubmed-author:PluschkeGerdG,
pubmed-author:SchrollerSandroS,
pubmed-author:TannerMarcelM,
pubmed-author:VounatsouPenelopeP,
pubmed-author:WesterfeldNicoleN,
pubmed-author:ZurbriggenRinaldoR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e1018
|
|
pubmed:meshHeading |
pubmed-meshheading:17925866-Adolescent,
pubmed-meshheading:17925866-Adult,
pubmed-meshheading:17925866-Animals,
pubmed-meshheading:17925866-Antigens, Viral,
pubmed-meshheading:17925866-Humans,
pubmed-meshheading:17925866-Malaria,
pubmed-meshheading:17925866-Malaria Vaccines,
pubmed-meshheading:17925866-Peptides,
pubmed-meshheading:17925866-Phosphatidylethanolamines,
pubmed-meshheading:17925866-Placebos,
pubmed-meshheading:17925866-Plasmodium falciparum,
pubmed-meshheading:17925866-Prospective Studies,
pubmed-meshheading:17925866-Time Factors,
pubmed-meshheading:17925866-Treatment Outcome,
pubmed-meshheading:17925866-Virosomes
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers.
|
|
pubmed:affiliation |
Swiss Tropical Institute, Basel, Switzerland. blaise.genton@unibas.ch
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
